<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>3159</number>
    <updateDate>2022-12-30T08:33:20Z</updateDate>
    <updateDateIncludingText>2022-12-30T08:33:20Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <type>S</type>
    <introducedDate>2021-11-03</introducedDate>
    <congress>117</congress>
    <committees>
      <item>
        <systemCode>ssfr00</systemCode>
        <name>Foreign Relations Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2021-11-03T22:04:34Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Fairness and Accountability in Underwriting Chinese Institutions Act</title>
        <congress>117</congress>
        <number>5988</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2021-11-17</actionDate>
          <text>Referred to the Subcommittee on Health.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2021-11-03</actionDate>
        <committees>
          <item>
            <systemCode>ssfr00</systemCode>
            <name>Foreign Relations Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Foreign Relations.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2021-11-03</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>E000295</bioguideId>
        <fullName>Sen. Ernst, Joni [R-IA]</fullName>
        <firstName>Joni</firstName>
        <lastName>Ernst</lastName>
        <party>R</party>
        <state>IA</state>
        <identifiers>
          <bioguideId>E000295</bioguideId>
        </identifiers>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>R000595</bioguideId>
        <fullName>Sen. Rubio, Marco [R-FL]</fullName>
        <firstName>Marco</firstName>
        <lastName>Rubio</lastName>
        <party>R</party>
        <state>FL</state>
        <identifiers>
          <bioguideId>R000595</bioguideId>
        </identifiers>
        <sponsorshipDate>2021-11-03</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B001310</bioguideId>
        <fullName>Sen. Braun, Mike [R-IN]</fullName>
        <firstName>Mike</firstName>
        <lastName>Braun</lastName>
        <party>R</party>
        <state>IN</state>
        <identifiers>
          <bioguideId>B001310</bioguideId>
        </identifiers>
        <sponsorshipDate>2021-11-03</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>W000437</bioguideId>
        <fullName>Sen. Wicker, Roger F. [R-MS]</fullName>
        <firstName>Roger</firstName>
        <lastName>Wicker</lastName>
        <party>R</party>
        <state>MS</state>
        <identifiers>
          <bioguideId>W000437</bioguideId>
        </identifiers>
        <middleName>F.</middleName>
        <sponsorshipDate>2021-11-03</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>T000250</bioguideId>
        <fullName>Sen. Thune, John [R-SD]</fullName>
        <firstName>John</firstName>
        <lastName>Thune</lastName>
        <party>R</party>
        <state>SD</state>
        <identifiers>
          <bioguideId>T000250</bioguideId>
        </identifiers>
        <middleName>R.</middleName>
        <sponsorshipDate>2021-11-16</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>International Affairs</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Asia</name>
        </item>
        <item>
          <name>Cardiovascular and respiratory health</name>
        </item>
        <item>
          <name>China</name>
        </item>
        <item>
          <name>Congressional oversight</name>
        </item>
        <item>
          <name>Department of Health and Human Services</name>
        </item>
        <item>
          <name>Drug trafficking and controlled substances</name>
        </item>
        <item>
          <name>Government employee pay, benefits, personnel management</name>
        </item>
        <item>
          <name>Government ethics and transparency, public corruption</name>
        </item>
        <item>
          <name>Government studies and investigations</name>
        </item>
        <item>
          <name>Health programs administration and funding</name>
        </item>
        <item>
          <name>Infectious and parasitic diseases</name>
        </item>
        <item>
          <name>Medical research</name>
        </item>
        <item>
          <name>National Institutes of Health (NIH)</name>
        </item>
        <item>
          <name>Public contracts and procurement</name>
        </item>
        <item>
          <name>Research administration and funding</name>
        </item>
        <item>
          <name>World health</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>International Affairs</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2021-11-03</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2022-06-06T18:29:05Z</updateDate>
        <text>
          <![CDATA[ <p><strong>Fairness and Accountability in Underwriting Chinese Institutions Act or the FAUCI Act</strong></p> <p>This bill prohibits making any federal funding available to laboratories or research institutions in China for gain-of-function research. The President may waive this prohibition for national security interests. (Under the bill, gain-of-function research generally involves the enhancement of potential pandemic pathogens or related risky research with potentially dangerous pathogens.)</p> <p>Furthermore, if the Office of the Inspector General of the Department of Health and Human Services determines that a National Institutes of Health official, employee, or grantee has intentionally misled or omitted information in a relevant disclosure (e.g., to Congress) about federal funding for international gain-of-function research, such a person shall be ineligible for any federal funding or federal employment. </p>]]>
        </text>
      </summary>
    </summaries>
    <title>Fairness and Accountability in Underwriting Chinese Institutions Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Fairness and Accountability in Underwriting Chinese Institutions Act</title>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <title>Fairness and Accountability in Underwriting Chinese Institutions Act</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <title>FAUCI Act</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>A bill to restrict the use of Federal Funds for gain-of-function research in the People's Republic of China.</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2021-11-03T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-117s3159is/xml/BILLS-117s3159is.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <date/>
        <formats/>
        <type/>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2021-11-03</actionDate>
      <text>Read twice and referred to the Committee on Foreign Relations.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
